Cytomegalovirus infection epidemiology and demographics

Jump to navigation Jump to search

Cytomegalovirus infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cytomegalovirus infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cytomegalovirus infection epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cytomegalovirus infection epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cytomegalovirus infection epidemiology and demographics

CDC on Cytomegalovirus infection epidemiology and demographics

Cytomegalovirus infection epidemiology and demographics in the news

Blogs on Cytomegalovirus infection epidemiology and demographics

Directions to Hospitals Treating Cytomegalovirus infection

Risk calculators and risk factors for Cytomegalovirus infection epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Kuchkuntla, M.B.B.S[2]

Overview

Worldwide, approximately 40,000 to 90,000 per 100,000 individuals are seropositive for Cytomegalovirus infection.

Epidemiology and Demographics

Prevalence

  • Worldwide, approximately 40,000 to 90,000 per 100,000 individuals are seropositive for Cytomegalovirus infection. [1]
  • CMV seroprevalence in developing countries reaches more than 90% by adolescence and exceeds 95% by early adulthood

Gender

  • In the United States, 35%-90% of women entering their childbearing years are seropositive, and thus, they are not susceptible to primary CMV infection.

Age

  • Seroprevalence is age-dependent 58.9% of individuals aged 6 and over are infected with CMV.
  • 90.8% of individuals aged 80 and over are positive for CMV.

References

  1. Pytka D, Czarkowska-Pączek B| title=[CMV infection in elderly]. | journal=Przegl Lek | year= 2016 | volume= 73 | issue= 4 | pages= 241-4 | pmid=27526428 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27526428 }}